Credit Suisse’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$6.87M Sell
99,555
-884,505
-90% -$59.7M 0.01% 1118
2023
Q4
$61.2M Sell
984,060
-102,312
-9% -$5.72M 0.06% 329
2023
Q3
$61M Sell
1,086,372
-263,329
-20% -$14.8M 0.06% 326
2023
Q2
$68.1M Buy
1,349,701
+381,471
+39% +$20.3M 0.07% 302
2023
Q1
$52.8M Buy
968,230
+5,248
+0.5% +$307K 0.05% 378
2022
Q4
$60.2M Sell
962,982
-160,044
-14% -$10.6M 0.06% 327
2022
Q3
$79.1M Sell
1,123,026
-490,947
-30% -$33.9M 0.09% 237
2022
Q2
$91.5M Sell
1,613,973
-290,663
-15% -$15.9M 0.1% 223
2022
Q1
$119M Sell
1,904,636
-368,562
-16% -$19.9M 0.1% 210
2021
Q4
$127M Buy
2,273,198
+64,421
+3% +$3.94M 0.07% 300
2021
Q3
$144M Sell
2,208,777
-397,586
-15% -$27.1M 0.08% 259
2021
Q2
$165M Buy
2,606,363
+10,780
+0.4% +$636K 0.09% 225
2021
Q1
$155M Buy
2,595,583
+64,602
+3% +$3.51M 0.08% 274
2020
Q4
$126M Buy
2,530,981
+568,745
+29% +$26.7M 0.06% 331
2020
Q3
$100M Buy
1,962,236
+448,281
+30% +$18.7M 0.06% 345
2020
Q2
$53.2M Buy
1,513,955
+1,505,074
+16,947% +$51.8M 0.04% 513
2020
Q1
$226K Sell
8,881
-6,271
-41% -$186K ﹤0.01% 3586
2019
Q4
$420K Buy
+15,152
New +$362K ﹤0.01% 3657
2019
Q3
Sell
-5,450
Closed -$223K 4294
2019
Q2
$223K Buy
+5,450
New +$153K ﹤0.01% 3811

Other funds holding AXNX

Credit Suisse's AXNX Position: Q1 2024 in Review

Credit Suisse reduced its Axonics, Inc. Common Stock (AXNX) stake by 90% in Q1 2024, selling an estimated $59.7M and leaving 99,555 shares worth $6.87M. The position accounts for 0.01% of the portfolio, ranked #1118.

Credit Suisse first reported a position in AXNX in Q2 2019 and has held it in 19 quarters since. The position peaked at $165M in Q2 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Credit Suisse held 99,555 shares of Axonics, Inc. Common Stock worth $6.87M as of Q1 2024.
  • Credit Suisse sold 884,505 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $59.7M.
  • Axonics, Inc. Common Stock made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1118 holding.
  • Credit Suisse first reported a position in Axonics, Inc. Common Stock in Q2 2019 and has held it in 19 quarters since.
  • Credit Suisse's Axonics, Inc. Common Stock position peaked at $165M in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.